Madison WI 胰腺癌临床试验
10项针对 胰腺癌的研究正在 Madison及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
招募中3 期
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
招募中1 期
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- UW Health Carbone Cancer Center, Madison
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US044, Madison
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0134, Madison
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中观察性研究
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
招募中2 期
- UW Health, Madison
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
招募中1/2 期
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University Telemedicine, Madison
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- University of Wisconsin, Madison
其他城市的 胰腺癌试验
- Houston, TX61 项研究
- New York City, NY60 项研究
- Boston, MA43 项研究
- Nashville, TN39 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO33 项研究
- Arlington, VA33 项研究
- Baltimore, MD31 项研究
- San Antonio, TX31 项研究
- Philadelphia, PA26 项研究
- Tampa, FL26 项研究
- Durham, NC24 项研究
Madison的其他研究
- 前列腺癌29 项研究
- 结直肠癌23 项研究
- 乳腺癌22 项研究
- 转移性癌症21 项研究
- 急性髓系白血病16 项研究
- 非小细胞肺癌16 项研究
- 黑色素瘤15 项研究
- 癌症（所有类型）14 项研究
- 卵巢癌13 项研究
- 胃癌11 项研究
- 肺癌10 项研究
- 多发性骨髓瘤9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。